{"artifact_id":"wiki-clinical-trials-pi-2620-tau-pet-phase-3-ftld-atypical-ad-nct05456503","artifact_type":"wiki_page","title":"PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD","quality_score":0.5,"is_latest":1,"version_number":2,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{"related":15,"see_also":2114},"total_incoming":2129,"outgoing_by_type":{"related":8,"see_also":2114,"mentions":14},"total_outgoing":2136,"quality_trajectory":[{"score":0.5,"at":"2026-04-28T03:48:49.857966-07:00"}],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":4265,"is_well_supported":false,"is_controversial":false,"is_foundational":false}